Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2007 by Cytogen Corporation.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Cytogen Corporation
ClinicalTrials.gov Identifier:
NCT00121095
First received: July 13, 2005
Last updated: December 17, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2008
  Estimated Primary Completion Date: No date given